Evidence map›Paper›PMID 27467505›Full record

ArticlePLoS neglected tropical diseases2016

Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model.

Luther A Bartelt, David T Bolick, Glynis L Kolling, James K Roche, Edna I Zaenker, Ana M Lara, Francisco Jose Noronha, Carrie A Cowardin, John H Moore, Jerrold R Turner and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Amixicile Reduces Severity of Cryptosporidiosis but Does Not HaveAntimicrobial agents and chemotherapy · 2018
    Article
  15. Article
  16. A rapid IL-17 response to Cryptosporidium parvum in the bovine intestine.Veterinary immunology and immunopathology · 2017
    Article
  17. Article
  18. The mucosal barrier at a glance.Journal of cell science · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Luther A BarteltDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
David T BolickDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Glynis L KollingDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
James K RocheDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Edna I ZaenkerDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Ana M LaraMolecular Biology and Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Francisco Jose NoronhaDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Carrie A CowardinDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
John H MooreDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Jerrold R TurnerDepartment of Pathology, The University of Chicago, Chicago, Illinois, United States of America.
Cirle A WarrenDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
Gregory A BuckMolecular Biology and Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America.
Richard L GuerrantDivision of Infectious Diseases and Center for Global Health, University of Virginia, Charlottesville, Virginia, United States of America.
University of Virginia · USCenter for Global Health · USVirginia Commonwealth University · USBrigham and Women's Hospital · USUniversity of North Carolina at Chapel Hill · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, JUDITH M. · 2003 to 2013
$91.5M
ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI LIU, CAMBRIAN YANGSHAO · 1990 to 2025
$29.8M
Shigella Live Vector-Based Multivalent VaccineU19AI109776 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LEVINE, MYRON MAX · 2014 to 2018
$25.4M
TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
Cytokine signaling and IEC restitution in enteropathy: the Giardia paradigmK08AI108730 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARTELT, LUTHER A · 2014 to 2018
$938k
NCI NIH HHS P30 CA014599NCRR NIH HHS UL1 RR024999NIAID NIH HHS K08 AI108730NIAID NIH HHS T32 AI007046NIAID NIH HHS U19 AI109776NIAID NIH HHS U54 AI057168NIDDK NIH HHS P30 DK042086NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271
6 · The paper itself

Abstract

Cryptosporidium is a major cause of severe diarrhea, especially in malnourished children. Using a murine model of C. parvum oocyst challenge that recapitulates clinical features of severe cryptosporidiosis during malnutrition, we interrogated the effect of protein malnutrition (PM) on primary and secondary responses to C. parvum challenge, and tested the differential ability of mucosal priming strategies to overcome the PM-induced susceptibility. We determined that while PM fundamentally alters systemic and mucosal primary immune responses to Cryptosporidium, priming with C. parvum (106 oocysts) provides robust protective immunity against re-challenge despite ongoing PM. C. parvum priming restores mucosal Th1-type effectors (CD3+CD8+CD103+ T-cells) and cytokines (IFNγ, and IL12p40) that otherwise decrease with ongoing PM. Vaccination strategies with Cryptosporidium antigens expressed in the S. Typhi vector 908htr, however, do not enhance Th1-type responses to C. parvum challenge during PM, even though vaccination strongly boosts immunity in challenged fully nourished hosts. Remote non-specific exposures to the attenuated S. Typhi vector alone or the TLR9 agonist CpG ODN-1668 can partially attenuate C. parvum severity during PM, but neither as effectively as viable C. parvum priming. We conclude that although PM interferes with basal and vaccine-boosted immune responses to C. parvum, sustained reductions in disease severity are possible through mucosal activators of host defenses, and specifically C. parvum priming can elicit impressively robust Th1-type protective immunity despite ongoing protein malnutrition. These findings add insight into potential correlates of Cryptosporidium immunity and future vaccine strategies in malnourished children.

Indexed as

Administration, IntranasalAnimalsCryptosporidiosisCryptosporidiumDietary ProteinsFemaleMalnutritionMiceMice, Inbred C57BLProtozoan VaccinesDietary ProteinsProtozoan Vaccines

Identifiers

PMID27467505
PMCPMC4965189
OpenAlexW2477661026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.